Skip to main content

Strahlentherapeutische Behandlung von Knochenmetastasen bei Tumorschmerzen

  • Chapter
  • First Online:
Praktische Schmerzmedizin

Part of the book series: Springer Reference Medizin ((SRM))

  • 6618 Accesses

Zusammenfassung

Die perkutane Strahlentherapie ist eine wirksame Maßnahme zur Reduktion der lokalen inflammatorischen Reaktion sowie zur Inaktivierung proliferativer Eigenschaften des Tumors. Daher verfügt sie über eine messbare Effektivität bei Schmerzen, die durch Knochenmetastasen hervorgerufen werden. Knochenmetastasen entstehen durch hämatogene Tumorzelldissemination in das Knochenmark und sind eigentlich Metastasen des Knochenmarks. Die dort wachsenden Tumorzellen können die Skelett- und Kalziumhomöostase stören und sekundäre Knochenveränderungen hervorrufen, die als Tumorosteopathien bezeichnet werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Adamietz IA, Diel IJ (2003) Bisphosphonate. Onkologe 9:495–509

    Article  Google Scholar 

  • Algur E, Macklis RM, Hafeli UO (2005) Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines. Int J Radiat Oncol Biol Phys 61:535–542

    Article  CAS  Google Scholar 

  • Arcangeli G, Giovinazzo G, Saracino B et al (1998) Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys 42:1119–1126

    Article  CAS  Google Scholar 

  • Blitzer PH (1985) Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer 55:1468–1472

    Article  CAS  Google Scholar 

  • Blum RH, Novetsky D, Shasha D et al (2003) The multidisciplinary approach to bone metastases. Oncology (Williston Park) 17:845–857; discussion 862–843, 867

    Google Scholar 

  • Bone-Trial-Working-Party (1999) 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol 52:111–121

    Article  Google Scholar 

  • Böttcher HD, Adamietz IA (1997) Klinik der Skelettmetastasen. Zuckschwerdt, München/Bern/Wien/New York

    Google Scholar 

  • Chow E, Zeng L, Salvo N et al (2012) Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol) 24:112–124

    Article  CAS  Google Scholar 

  • Coleman RE, Gnant M (2009) New results from the use of bisphosphonates in cancer patients. Curr Opin Support Palliat Care 3:213–218

    Article  Google Scholar 

  • Dempster DW, Lambing CL, Kostenuik PJ et al (2012) Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. Clin Ther 34:521–536

    Article  CAS  Google Scholar 

  • Enright K, Clemons M, Chow E (2004) Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience. Support Care Cancer 12:48–52

    Article  Google Scholar 

  • Expert Panel on Radiation Oncology-Bone Metastases, Lutz ST, Lo SS et al (2012) Appropriateness Criteria® non-spine bone metastases. J Palliat Med 15:521–526

    Article  Google Scholar 

  • Gnant M (2009) Bisphosphonates in the prevention of disease recurrence: current results and ongoing trials. Curr Cancer Drug Targets 9:824–883

    Article  CAS  Google Scholar 

  • Habl G, Straube C, Schiller K, Duma MN et al (2017) Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT). BMC Cancer 17:361–371. https://doi.org/10.1186/s12885-017-3341-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Henry DH, Costa L, Goldwasser F et al (2001) Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 29:1125–1132

    Article  Google Scholar 

  • Hoskin PJ (2003) Bisphosphonates and radiation therapy for palliation of metastatic bone disease. Cancer Treat Rev 29:321–327

    Article  CAS  Google Scholar 

  • Huisman M, van den Bosch MA, Wijlemans JW et al (2012) Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 84:8–14

    Article  Google Scholar 

  • Johnstone C, Lutz ST (2014) External beam radiotherapy and bone metastases. Ann Palliat Med 3:114–122. https://doi.org/10.3978/j.issn.2224-5820.2014.04.06

    Article  PubMed  Google Scholar 

  • Kagan AR, Rose CM, Bedwinek JM et al (2000) Bone metastases. American College of Radiology. ACR appropriateness criteria. Radiology 215:1077–1104

    PubMed  Google Scholar 

  • Kijima T, Fujii Y, Suyama T et al (2009) Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate. BJU Int 103:620–624

    Article  CAS  Google Scholar 

  • Kimura T (2018) Multidisciplinary approach for bone metastasis: a review. Cancer 10:156–165. https://doi.org/10.3390/cancers10060156

    Article  Google Scholar 

  • Koswig S, Budach V (1999) Remineralisation und Schmerzlinderung von Knochenmetastasen nach unterschiedlich fraktionierter Strahlentherapie (10mal 3 Gy vs. 1mal 8 Gy). Strahlenther Onkol 175:500–508

    Article  CAS  Google Scholar 

  • Koswig S, Buchali A, Bohmer D et al (1999) Palliative Strahlentherapie von Knochenmetastasen. Eine retrospektive Analyse von 176 Patienten. Strahlenther Onkol 175:509–514

    Article  CAS  Google Scholar 

  • Lutz S, Berk L, Chang E et al (2011) Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 79:965–976

    Article  Google Scholar 

  • Macedo F, Ladeira K, Pinho F, Saraiva N et al (2017) Bone metastases: an overview. Oncol Rev 11:321–327

    Article  Google Scholar 

  • Mercadante S (2006) Scoring the effect of radiotherapy for painful bone metastases. Support Care Cancer 14:967–969

    Article  Google Scholar 

  • Mercadante S, Fulfaro F (2007) Management of painful bone metastases. Curr Opin Oncol 19:308–314

    Article  Google Scholar 

  • Rieden K, Adolph J, Lellig U et al (1989a) Strahlentherapeutischer Effekt bei knochenmetastasen in Abhängigkeit von der Metastasenhäufig, Metastasenlokalisation und der Histologie des Primärtumors. Strahlenther Onkol 165:380–385

    CAS  PubMed  Google Scholar 

  • Rieden K, Mende U, Adolph J et al (1989b) Akzelerierte Bestrahlung von Knochenmetastasen. Strahlenther Onkol 165:23–27

    CAS  PubMed  Google Scholar 

  • Saad F (2006) Bone-directed treatments for prostate cancer. Hematol Oncol Clin North Am 20:947–963

    Article  Google Scholar 

  • Saad F (2008) New research findings on zoledronic acid: survival, pain, and anti-tumour effects. Cancer Treat Rev 34:183–192

    Article  CAS  Google Scholar 

  • Saad F, Abrahamsson PA, Miller K (2009) Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates. BJU Int 104:1573–1579

    Article  CAS  Google Scholar 

  • Salazar OM, DaMotta NW, Bridgman SM et al (1996) Fractionated half-body irradiation for pain palliation in widely metastatic cancers: comparison with single dose. Int J Radiat Oncol Biol Phys 36:49–60

    Article  CAS  Google Scholar 

  • Salazar OM, Sandhu T, da Motta NW et al (2001) Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys 50:765–775

    Article  CAS  Google Scholar 

  • Sauer N, Leising D, Wild B et al (2006) Der Einfluss palliativer Strahlentherapie auf Schmerz und Lebensqualitat bei Patienten mit Knochenmetastasen. Strahlenther Onkol 182:550–556

    Article  Google Scholar 

  • Souchon R, Wenz F, Sedlmayer F et al (2009) DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC). Strahlenther Onkol 185:417–424

    Article  Google Scholar 

  • Sprave T, Hees K, Bruckner T et al (2018) The influence of fractionated radiotherapy on the stability of spinal bone metastases: a retrospective analysis from 1047 cases. Radiat Oncol 13:134–142. https://doi.org/10.1186/s13014-018-1082-2

    Article  PubMed  PubMed Central  Google Scholar 

  • Stopeck AT, Lipton A, Body JJ et al (2010) Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blinded study. J Clin Oncol 28:5132–5239

    Article  CAS  Google Scholar 

  • Tong D, Gillick L, Hendrickson FR (1982) The palliation of symptomatic osseous metastases: final results of the study by the radiation therapy oncology group. Cancer 50:893–899

    Article  CAS  Google Scholar 

  • Tsuya A, Kurata T, Tamura K et al (2007) Skeletal metastases in non-small cell lung cancer: a retrospective study. Lung Cancer 57:229–232

    Article  Google Scholar 

  • Ural AU, Avcu F, Candir M et al (2006) In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells. Breast Cancer Res 8:R52

    Article  Google Scholar 

  • Wu JS, Wong R, Johnston M et al (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55:594–605

    Article  Google Scholar 

  • Wu JS, Monk G, Clark T et al (2006) Palliative radiotherapy improves pain and reduces functional interference in patients with painful bone metastases: a quality assurance study. Clin Oncol (R Coll Radiol) 18:539–544

    Article  CAS  Google Scholar 

  • Yu HH, Hoffe SE (2012) Beyond the conventional role of external-beam radiation therapy for skeletal metastases: new technologies and stereotactic directions. Cancer Control 19:129–136

    Article  Google Scholar 

  • Zeng L, Lutz S, Chow E et al (2012) Recent important developments in the management of nonspine bone metastases. Curr Opin Support Palliat Care 6:80–84

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Irenäus A. Adamietz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Adamietz, I.A., Schmidberger, H. (2019). Strahlentherapeutische Behandlung von Knochenmetastasen bei Tumorschmerzen. In: Baron, R., Koppert, W., Strumpf, M., Willweber-Strumpf, A. (eds) Praktische Schmerzmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57487-4_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57487-4_17

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57486-7

  • Online ISBN: 978-3-662-57487-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics